SABS

Conviction 61HealthcareScan · Fri, Jun 26, 2026

SABS$3.79-2.07%

ResistanceSupportVol 14

Vol MA14 1.45M

Mar 27Apr 15May 4May 20Jun 9Jun 26

SAB Biotherapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.sab.bio ↗

Price3.79

Change-2.07%

Gap-1.29%

Rel volume5.94×

Avg volume1.12M

Avg $ vol4.25M

SMA 203.61

SMA 503.69

SMA 2003.55

Price vs 50+2.76%

Price vs 200+6.74%

MA stackbullish

50/200 cross—

Supertrendup · 3.22

RSI (14)53

MACD hist0.04

MACD crossbull · 8d

Stoch %K / %D55 / 60

ADX (14)25

+DI / −DI25 / 15

RSI divergence—

MACD divergenceBullish

ATR %+6.50%

ADR %6.11%

52w high4.59

52w low1.69

From 52w high-17.43%

Above 52w low+124.26%

New 52w highNo

SqueezeOff

Bollinger width26.36%

%B0.69

Donchian pos56.04%

Donchian high4.19

Donchian low3.28

AVWAP (52w high)3.77

vs AVWAP high+0.47%

AVWAP (52w low)3.77

vs AVWAP low+0.59%

OBV trendFlat

Chaikin MF (20)-0.12

Today vs 20d5.94×

Avg vol (14d)1.45M

Avg vol (20d)1.12M

Avg $ vol (20d)4.25M

Market cap—

RS 3m (vs SPY)-10.49%

RS 6m (vs SPY)-6.44%

RS line new highNo

Trend template5/8

Technical rank56.3

1 week-5.25%

1 month+5.28%

3 months-1.04%

6 months-1.30%

1 year+108.24%

YTD+0.53%

P/E22.38

P/B1.31

P/S—

P/FCF-6.50

EPS-0.7900

Div yield—

ROE5.84%

ROA5.34%

Debt/Eq—

Current11.45

EV/EBITDA-6.02

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth138.92%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value276.54M

Revenue263.14K

Net income-18.87M

Gross profit—

Free cash flow-45.71M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out76.46M

Employees86

ListedFri, Oct 22, 2021

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction61 / 100

Pattern quality—

Tech rank56.3 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.39

Support3.29

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SABS

All disclosures →

No recent disclosed trades by Congress in SABS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SABS

No recent insider (Form 4) filings in SABS. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in SABS · 1 recent

EDGAR →

8-K8-KThu, Jun 18, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.